XML 18 R5.htm IDEA: XBRL DOCUMENT v3.5.0.2
CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
6 Months Ended
Jun. 30, 2016
Jun. 30, 2015
Cash flows from operating activities:    
Net loss $ (11,743,000) $ (17,509,000)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 574,000 510,000
Amortization of deferred financing costs and debt discount 468,000 500,000
Joint Venture acquisition obligation accretion 24,000 307,000
Provision for expired inventory 26,000 0
Change in fair value of warrants 0 2,322,000
Stock-based compensation expense 645,000 1,146,000
Loss on asset disposal 2,000 0
Loss on debt extinguishment 0 260,000
Increases (decreases) in cash caused by changes in operating assets and liabilities:    
Accounts receivable 66,000 544,000
Inventories (380,000) 730,000
Other current assets 137,000 (106,000)
Other assets 34,000 407,000
Accounts payable and accrued expenses (431,000) 1,089,000
Deferred revenues 1,000 151,000
Long-term deferred rent (158,000) (139,000)
Net cash used in operating activities (10,735,000) (9,788,000)
Cash flows from investing activities:    
Purchases of property and equipment (105,000) (497,000)
Expenditures for intellectual property 0 (13,000)
Net cash used in investing activities (105,000) (510,000)
Cash flows from financing activities:    
Principal payments on long-term obligations 0 (25,032,000)
Proceeds from long-term obligations 0 17,700,000
Debt issuance costs and loan fees 0 (1,854,000)
Joint Venture purchase payments (1,774,000) (1,123,000)
Proceeds from exercise of employee stock options and warrants 0 4,986,000
Proceeds from sale of common stock, net 18,179,000 24,930,000
Dividends paid on preferred stock 0 (75,000)
Net cash provided by financing activities 16,405,000 19,532,000
Effect of exchange rate changes on cash and cash equivalents 139,000 (14,000)
Net increase in cash and cash equivalents 5,704,000 9,220,000
Cash and cash equivalents at beginning of period 14,338,000 14,622,000
Cash and cash equivalents at end of period 20,042,000 23,842,000
Cash paid during period for:    
Interest 805,000 1,202,000
Supplemental schedule of non-cash investing and financing activities:    
Conversion of preferred stock into common stock 0 10,000
Declared dividend related to preferred stock $ 0 $ 3,000